What is Bortezomib-lenalidomide-dexamethasone (VRd)?
CATEGORY:
Bortezomib-lenalidomide-dexamethasone, also known as VRd, is a regimen that may be used for the treatment of multiple myeloma. It contains the anticancer agents bortezomib and lenalidomide along with dexamethasone, a corticosteroid.
Save up to 80% off your prescriptions!
How do members experience Bortezomib-lenalidomide-dexamethasone (VRd)?
Top 5 reported purposes & perceived effectiveness
Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Multiple myeloma | 447 | 32 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Fatigue | 10 | |
Constipation | 5 | |
Diarrhea | 4 | |
Neuropathy in feet | 3 | |
Nerve pain (neuralgia) | 2 | |
Peripheral neuropathy | 2 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 2 | |
Moderate | 14 | |
Mild | 15 | |
None | 1 |
Learn more about our community’s experience with Bortezomib-lenalidomide-dexamethasone (VRd)
What are people saying about Bortezomib-lenalidomide-dexamethasone (VRd)?
487
487
members have reported taking Bortezomib-lenalidomide-dexamethasone (VRd)
Join the conversation and connect with people who have taken Bortezomib-lenalidomide-dexamethasone (VRd)
Last updated: